直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

To Stay or Not to Stay: The Federal Circuit Weighs In

July 24, 2014

Authored and Edited by Shaton C. Menzie

In a 2-1 decision, the Federal Circuit in VirtualAgility, Inc. v. Salesforce.com, Inc., held that the district court abused its discretion in denying a motion to stay pending CBM review.

Specifically, the Court determined that the district court misapplied the four-factor test codified in AIA Section 18(b)(1) as follows:

  • Simplification of Issues: This factor heavily weighed in favor of granting a stay because the PTAB “expressly determined that all of the claims are more likely than not unpatentable” when it instituted CBM review. The Court held that “[t]he district court erred as a matter of law to the extent that it decided to ‘review’ the PTAB’s determination that the claims of the [] patent are more likely than not invalid in the posture of a ruling on a motion to stay,” deeming the district court’s challenge of that determination an “improper collateral attack on the PTAB’s decision to institute CBM review.”
  • Whether Discovery is Complete and a Trial Date Set: The district court correctly found that this factor favored a stay because the litigation was “still at its infancy.” Though not impacting the decision, the Federal Circuit clarified that “the time of the motion is the relevant time to measure the stage of litigation,” not the time of the ruling.
  • Undue Prejudice: The district court “erred in finding that the undue prejudice factor weighed heavily against a stay … at best, this factor weighs slightly against a stay.” The Court noted that “the evidence of competition [between the parties] is weak and the patentee’s delays in pursuing suit and seeking preliminary injunctive relief belie its claims that it will be unduly prejudiced by a stay.”
  • Reducing Burden of Litigation: While confirming that this factor must be separately weighed, the Court held that this factor weighed heavily in favor of a stay for many of the same reasons outlined in the first Simplification of Issues factor.

Judge Newman dissented, stating that the decision “effectively creates a rule that stays of district court litigation pending CBM review must always be granted,” even though the AIA does not make stays mandatory and the district court retains “discretionary authority to manage its cases.”

This decision provides additional support for defendant-petitioners seeking stays pending CBM review when CBM petitions and stay motions are filed early in litigation, and particularly after receiving the PTAB’s decision to institute CBM review.

Tags

District Court, motion to stay, United States Court of Appeals for the Federal Circuit (CAFC)

Copyright © 2014 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. Additional disclaimer information. 

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Charitable

Banding Together 2026

June 18, 2026

Washington, DC

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP